SCHEMBL503847

SCHEMBL503847

CCCCC(N)C(=O)OC(=O)C(CCCCN)NC(=O)C(N)CCCCN

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 10/20 0.58
▸ DPP9 Q86TI2 8/20 0.58
▸ DPP8 Q6V1X1 7/20 0.58
▸ DPP4 P27487 5/20 0.52
▸ GNAI3 P08754 1/20 0.51
▸ GNAO1 P09471 1/20 0.51
▸ GNAI1 P63096 1/20 0.51
▸ ERAP2 Q6P179 2/20 0.51
▸ LNPEP Q9UIQ6 1/20 0.51
▸ ERAP1 Q9NZ08 1/20 0.50
▸ SIRT6 Q8N6T7 1/20 0.44
▸ SIRT1 Q96EB6 1/20 0.44
▸ TLR2 O60603 2/20 0.44
▸ SLC15A1 P46059 1/20 0.43
▸ NOD1 Q9Y239 2/20 0.41
▸ RRM1 P23921 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7747523 1.00 DPP7 (0.58) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL1484685 0.85 GNAI3 (0.53) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL6844633 0.83 DPP8 (0.46) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL29570054 0.83 DPP7 (0.63) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL28157777 0.83 DPP7 (0.63) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL25169014 0.83 DPP7 (0.63) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL25169012 0.83 DPP7 (0.63) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL13496274 0.83 ERAP2 (0.54) DPP7DPP9DPP8DPP4GNAI3
SCHEMBL8811607 0.81 DPP7 (0.55) DPP7DPP9DPP8DPP4ERAP2
SCHEMBL8811612 0.81 DPP7 (0.55) DPP7DPP9DPP8DPP4ERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642728-B2 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor CAMBRIDGE ENTERPRISE LTD. (GB) 2014-02-04 — — US disclosed
US-20130280273-A1 Modulation of the Activity and Differentiation of Cells Expressing the Osteoclast-Associated Receptor CAMBRIDGE ENTPR LTD (GB) 2013-10-24 — — US disclosed
US-20120028903-A1 MODULATION OF THE ACTIVITY AND DIFFERENTIATION OF CELLS EXPRESSING THE OSTEOCLAST-ASSOCIATED RECEPTOR CAMBRIDGE ENTERPRISE LIMITED (GB) 2012-02-02 — — US disclosed
CN-102282169-A Modulation of cellular activity and differentiation of osteoclast-associated receptors — 2011-12-14 — — CN disclosed
EP-2344530-A1 MODULATION OF THE ACTIVITY AND DIFFERENTIATION OF CELLS EXPRESSING THE OSTEOCLAST-ASSOCIATED RECEPTOR Cambridge Enterprise Limited (GB) 2011-07-20 — — EP disclosed
WO-2010040998-A1 MODULATION OF THE ACTIVITY AND DIFFERENTIATION OF CELLS EXPRESSING THE OSTEOCLAST-ASSOCIATED RECEPTOR CAMBRIDGE ENTERPRISE LLIMITED (GB) 2010-04-15 — — WO disclosed
WO-2007052067-A2 VON WILLEBRAND FACTOR (VWF) BINDING PEPTIDES CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-05-10 — — WO disclosed
WO-2007017671-A1 COLLAGEN PEPTIDES, METHODS AND USES CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-02-15 — — WO disclosed
EP-1068313-A2 COLLAGEN PEPTIDES AND USES THEREOF CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2001-01-17 — — EP disclosed
WO-1999050281-A2 COLLAGEN PEPTIDES AND USES THEREOF CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 1999-10-07 — — WO disclosed
Send feedback